<DOC>
	<DOCNO>NCT01822535</DOCNO>
	<brief_summary>The ability maintain normal body core temperature ( Tcore = 98.6°F ) impair person tetraplegia . Despite known challenge ability person spinal cord injury ( SCI ) maintain Tcore , effect hypothermia impair mental function able-bodied ( AB ) person , work date address issue person tetraplegia . The aim study determine exposure 2 hr cool temperature ( 64°F ) cause body core temperature decrease person tetraplegia decrease related decrease mental performance . After sit cool ( 64°F ) room 2 hour investigator hypothesis : Hypotheses ( 1 ) : Tcore person tetraplegia decline approximately 1.8°F ( e.g. , 98.6 96.8°F ) Tcore control decline ; ( 2 ) Most person tetraplegia show decline mental performance ( memory clear-headedness ) AB control show decline . The second aim study determine 10 mg dose approve blood pressure raise medicine ( midodrine hydrochloride ) ( 1 ) reduce decrease body core temperature ( 2 ) prevent delay decline mental performance group tetraplegia compare exact procedure perform day medicine ( Visit 1 ) group . Hypotheses ( 3 &amp; 4 ) : The change blood flow skin cause take one-time dose midodrine lessen decline Tcore prevent delay decline mental performance compare change Tcore mental performance cool temperature exposure without midodrine group tetraplegia .</brief_summary>
	<brief_title>Body Temperature Persons With Tetraplegia When Exposed Cold</brief_title>
	<detailed_description>This study investigate mechanism contribute thermoregulatory fragility person tetraplegia expose cool ambient temperature routinely encountered activity daily live ( ADL ) . Subnormal body core temperature vulnerability hypothermia ( Tcore &lt; 95°F ) report veteran tetraplegia upon exposure relatively mild environmental temperature . The impact drift Tcore expect cognitive performance , specifically work memory executive function , demonstrate . These 2 area cognitive performance vital ability optimally care one 's self , person higher cord lesion must excel ensure health , well able attain maximal degree independence possible . Administration alpha agonist , midodrine hydrochloride , attempt attenuate drift Tcore prevent delay expect decline cognitive performance exposure cool cognitive function investigate well . Primary Specific Aim : To determine change : ( 1 ) Tcore ( 2 ) cognitive performance ( attention , work memory , process speed , executive function ) person tetraplegia exposure cool environment ( 64°F ) 120 min seat position . Primary Hypotheses : ( 1 ) 66 % person tetraplegia demonstrate decline 1.8°F Tcore 0 % control demonstrate thermal decline ; ( 2 ) 80 % person tetraplegia decline least 1 T-score Stroop Interference score ( executive functioning ) 30 % control demonstrate magnitude decline . Secondary Specific Aims : To determine change : ( 1 ) average distal skin temperature , ( 2 ) metabolic rate , ( 3 ) subjective rating thermal sensitivity exposure 64°F seat position . Secondary Hypotheses : Persons tetraplegia less percent change average distal skin temperature metabolic rate , report low thermal sensitivity rating compare AB . Tertiary Specific Aim : To determine single , 10 mg dose midodrine ( 1 ) reduce decrease Tcore ( 2 ) prevent delay decline cognitive performance group tetraplegia . Tertiary Hypotheses : Because administration peripheral alpha-agonist address primary thermoregulatory impairment cool temperature exposure person tetraplegia—that , lack vasoconstriction , midodrine-induced peripheral vasoconstriction anticipate blunt decrease Tcore prevent delay decline cognitive performance compare cool exposure without drug administration . Preparation Study Visits : The study visit separate minimum 1 day 14 day . Subjects wear minimal clothing ( gym short , sport bra ) study maximize bare skin exposure cool temperature . Each subject ask eat light , standard meal 2 hour prior schedule visit consist either plain bagel 2 piece toast . For visit ask empty bladder prior arrival upon arrival , need . Visit 1 : Cold Ambient Challenge : Instrumentation : During Visit 1 , subject transfer padded table instrumentation , transfer back wheelchair , control , provide wheelchair . All subject use Roho seat cushion air circulation consistency decubiti prevention . A rectal probe place 4 inch beyond anal sphincter core temperature measurement , skin thermal sensor tap 15 site level lesion collection skin temperature . A mask place subject 's nose mouth measurement exhale gas rest metabolic rate calculate analysis expire gas ( VO2 ) metabolic cart . Laser Doppler flowmetry ( LDF ) use measure change microvascular perfusion tap doppler probe skin area ulnar styloid process medial malleoli bilaterally ( wrist ankle ) confirm vasoconstriction . A pulse oximeter place left second digit obtain blood oxygen saturation heart rate ( HR ) . An automated blood pressure cuff place right elbow measure brachial BP . An intravenous catheter place right antecubital nearby vein secure sequential blood collection cortisol norepinephrine . Baseline Collection : At end 30 minute acclimation period ( 81°F ) , baseline ( BL ) collection follow parameter perform 15 minute Tcore , skin temperature , VO2 measure continuously ; HR , BP , blood oxygen saturation , subjective measure thermal sensitivity , 5 minute LDF measure 10 minute interval . A venous blood draw collect baseline norepinephrine cortisol concentration . At end BL period , cognitive performance battery administer . Thermal Challenge : Following completion baseline period , subject wheel 18°C thermal chamber 120 minute Tcore ≤ 95°F . Tcore , skin temperature , VO2 continuously monitor ensure subject safety throughout protocol ; brachial BP , HR , blood oxygen saturation , thermal sensitivity , symptom hypothermia autonomic dysreflexia assess 10 min interval LDF measure 5 minute every 20 minute . Venous blood collect 50 minute interval . A decrease Tcore ≤ 95°F , moderate subject discomfort , result termination protocol . The cognitive performance battery administer Tcore decline 1.8°F ≤ 95.9°F ( subject tetraplegia ) 120 minute cold exposure ( group ) Visits 1 &amp; 2 . Visit 2 : Cold Ambient Challenge Midodrine : Visit 2 complete subject tetraplegia participate Visit 1 impaired ability maintain Tcore . Following completion BL period , subject orally administer midodrine hydrochloride ( 10 mg tablet ) . Forty minute midodrine administration ( onset drug effect ) , second BL collection obtain , subject wheel 64°F thermal chamber 120 minute Tcore ≤ 95°F . Data collection follow schedule conduct seated position Visit 1 . If brachial BP increase 160/90 mmHg , subject remove cool room evaluate Dr. William A. Bauman , may consider administration labetalol ( low BP ) , deem necessary .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Quadriplegia</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>( 1 ) Between 18 68 year age ; ( 2 ) Duration injury ≥ 1 year ; ( 2 ) Level SCI C3T1 ; ( 3 ) Euhydration ( subject instruct avoid caffeine alcohol , maintain normal salt water intake , avoid strenuous exercise 24 hour prior study ) ( 1 ) Known coronary heart , kidney , peripheral vascular cerebral vascular disease ; ( 2 ) High blood pressure ; ( 3 ) Untreated thyroid disease ; ( 4 ) Diabetes mellitus ; ( 5 ) Acute illness infection ; ( 6 ) Dehydration ; ( 7 ) Known allergy midodrine hydrochloride ; ( 8 ) Smoking ; ( 9 ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Quadriplegia</keyword>
	<keyword>Spinal Cord Injuries</keyword>
	<keyword>Body Temperature Regulation</keyword>
	<keyword>Mild Cognitive Impairment</keyword>
</DOC>